Clinical Trial Detail

NCT ID NCT02339168
Title Enzalutamide and Metformin Hydrochloride in Treating Patients With Hormone-Resistant Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase I
Variant Requirements No
Sponsors University of California, Davis
Indications

prostate cancer

Therapies

Enzalutamide + Metformin

Age Groups: adult

No variant requirements are available.